26 related articles for article (PubMed ID: 29077232)
1. IGF2BPs as novel m
Duan M; Liu H; Xu S; Yang Z; Zhang F; Wang G; Wang Y; Zhao S; Jiang X
Genes Dis; 2024 Mar; 11(2):890-920. PubMed ID: 37692485
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature.
de Almeida BC; Dos Anjos LG; Dobroff AS; Baracat EC; Yang Q; Al-Hendy A; Carvalho KC
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289829
[TBL] [Abstract][Full Text] [Related]
3. The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology.
Xu X; Shen HR; Zhang JR; Li XL
Reprod Biol Endocrinol; 2022 Jun; 20(1):89. PubMed ID: 35706003
[TBL] [Abstract][Full Text] [Related]
4. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
Zhang P; Zhang H; Wang Y
Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives.
Mancarella C; Scotlandi K
Front Cell Dev Biol; 2019; 7():363. PubMed ID: 32010687
[TBL] [Abstract][Full Text] [Related]
6. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Tsuyoshi H; Yoshida Y
Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
[TBL] [Abstract][Full Text] [Related]
7. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
[TBL] [Abstract][Full Text] [Related]
8. Ki67 as a prognostic marker in uterine leiomyosarcoma: A quantitative systematic review.
Travaglino A; Raffone A; Catena U; De Luca M; Toscano P; Del Prete E; Vecchione ML; Lionetti R; Zullo F; Insabato L
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():119-124. PubMed ID: 34624740
[TBL] [Abstract][Full Text] [Related]
9. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma.
Davidson B; Kjæreng ML; Førsund M; Danielsen HE; Kristensen GB; Abeler VM
Am J Clin Pathol; 2016 Apr; 145(4):449-58. PubMed ID: 27149024
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort.
Garcia C; Kubat JS; Fulton RS; Anthony AT; Combs M; Powell CB; Littell RD
Int J Gynecol Cancer; 2015 May; 25(4):622-8. PubMed ID: 25675041
[TBL] [Abstract][Full Text] [Related]
11. Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma.
Cornejo K; Shi M; Jiang Z
Hum Pathol; 2012 Oct; 43(10):1567-72. PubMed ID: 22497850
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Simoni A; Taddei A; Taddei GL
J Chemother; 2003 Dec; 15(6):596-602. PubMed ID: 14998087
[TBL] [Abstract][Full Text] [Related]
13. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma.
Yasutake N; Ohishi Y; Taguchi K; Hiraki Y; Oya M; Oshiro Y; Mine M; Iwasaki T; Yamamoto H; Kohashi K; Sonoda K; Kato K; Oda Y
Histopathology; 2018 Apr; 72(5):739-748. PubMed ID: 29077232
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
